CD44 and urinary bladder cancer: In breast and urinary bladder cancer cell lines, CD44 knockdown inhibits cell invasion and tumorigenicity via STAT3 phosphorylation blockade, while anti-CD44 blocking antibody treatment downregulates STAT3 levels in rat atrial fibroblasts, suggesting that CD44 can regulate both STAT3 expression and activation (80–83).